Co-Diagnostics, Inc. Announces Third Quarter 2021 Earnings Release Date And Webcast

Rhea-AI Summary

Co-Diagnostics, Inc. (NASDAQ: CODX) will announce its third quarter 2021 financial results on November 11, 2021, post-market close. A conference call and webcast will occur at 4:30 p.m. EDT the same day to discuss these results, featuring CEO Dwight Egan, CFO Brian Brown, and Andrew Benson from Investor Relations. The company's diagnostics technology focuses on the detection of DNA and RNA molecules and is utilized across various industries.

SALT LAKE CITY, Oct. 28, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its third quarter 2021 results on Thursday, November 11, 2021, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. EDT to discuss its financial results with analysts and institutional investors.  Management on the call will include Dwight Egan, CEO, Brian Brown, CFO, and Andrew Benson, Investor Relations.

The call and webcast will be available via:

Webcast:	ir.codiagnostics.com on the Events & Webcasts page
Conference Call:	877-317-6789 (domestic) or 412-317-6789 (international)

If you are unable to participate during the live webcast, the call will be recorded and later made available on the Company's website.

About Co-Diagnostics, Inc.
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures, and markets a state-of-the-art diagnostics technology. The Company's technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-announces-third-quarter-2021-earnings-release-date-and-webcast-301411226.html

SOURCE Co-Diagnostics

FAQ

When will Co-Diagnostics release its third quarter 2021 results?

Co-Diagnostics will release its third quarter 2021 results on November 11, 2021, after the market close.

What time is the Co-Diagnostics conference call?

The Co-Diagnostics conference call is scheduled for 4:30 p.m. EDT on November 11, 2021.

Who will participate in the Co-Diagnostics earnings call?

The earnings call will feature CEO Dwight Egan, CFO Brian Brown, and Investor Relations Andrew Benson.

Where can I listen to the Co-Diagnostics webcast?

The Co-Diagnostics webcast can be accessed on their Events & Webcasts page at ir.codiagnostics.com.